Dr. Reddys Labs (NYSE: RDY) reported Q1 EPS of ($0.28), $0.89 worse than the analyst estimate of $0.61. Revenue for the quarter came in at $0 versus the consensus estimate of $742.49 million.

For earnings history and earnings-related data on Dr. Reddys Labs (RDY) click here.